Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 7-8: HPV vaccination: from seroprevalence to public health policy and everything in between
Submit an article Journal homepage
4,229
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain

Jesús De La Fuentea Unit of Lower Genital Tract Pathology, Department of Obstetrics and Gynecology, Hospital Universitario Infanta Leonor, Madrid, SpainView further author information
,
Juan José Hernandez Aguadoa Unit of Lower Genital Tract Pathology, Department of Obstetrics and Gynecology, Hospital Universitario Infanta Leonor, Madrid, SpainView further author information
,
María San Martínb Medical Department, MSD Spain, Madrid, SpainView further author information
,
Paula Ramirez Boixc Outcomes Research, MSD Spain, Madrid, SpainView further author information
,
Sergio Cedillo Gómezc Outcomes Research, MSD Spain, Madrid, SpainView further author information
&
Noelia Lópezb Medical Department, MSD Spain, Madrid, SpainCorrespondence[email protected]
View further author information
Pages 1949-1961 | Received 06 Sep 2018, Accepted 09 Dec 2018, Published online: 20 Feb 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, Queenie Wing-Lei Wong, Andrew Pavelyev, Isaya Sukarom & Kunal Saxena. (2023) Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong. Human Vaccines & Immunotherapeutics 19:2.
Read now
Gregory D. Zimet & Nosayaba Osazuwa-Peters. (2019) There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination. Human Vaccines & Immunotherapeutics 15:7-8, pages 1459-1464.
Read now

Articles from other publishers (12)

Didik Setiawan, Andi Nurul Annisa, Lianawati, Raymond C.W. Hutubessy & Karene Hoi Ting Yeung. (2023) The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia. Value in Health Regional Issues 35, pages 102-108.
Crossref
Juan J. Hernández-Aguado, Jesús de La Fuente-Valero, Mar Ramírez Mena, Luis Ortega-Medina, José Antonio Vidart Aragón & Juan Carlos Galán. (2023) Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study. Enfermedades infecciosas y microbiologia clinica (English ed.) 41:5, pages 262-268.
Crossref
Juan J. Hernández-Aguado, Jesús de La Fuente-Valero, Mar Ramírez Mena, Luis Ortega-Medina, José Antonio Vidart Aragón & Juan Carlos Galán. (2023) Estudio piloto comparativo del test VPH con genotipado parcial en primera línea frente a otras estrategias de cribado poblacional del cáncer de cérvix. Estudio CRYGEN 16/18. Enfermedades Infecciosas y Microbiología Clínica 41:5, pages 262-268.
Crossref
Kris Doggen, Albert Jan van Hoek & Jeroen Luyten. (2023) Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella. PharmacoEconomics 41:5, pages 481-497.
Crossref
Samruddhi H Charde & Rupesh A Warbhe. (2022) Human Papillomavirus Prevention by Vaccination: A Review Article. Cureus.
Crossref
Yi Tao, Huarui Shao, Ting Zhang, Junliang Pu & Chengyong Tang. (2022) Factors Influencing Men’s Attitudes toward HPV Vaccination in Males Included in the Chinese National Immunization Program. Vaccines 10:7, pages 1054.
Crossref
Renata Linertová, Carmen Guirado-Fuentes, Javier Mar Medina, Iñaki Imaz-Iglesia, Leticia Rodríguez-Rodríguez & Montserrat Carmona-Rodríguez. (2021) Cost-effectiveness of extending the HPV vaccination to boys: a systematic review. Journal of Epidemiology and Community Health 75:9, pages 910-916.
Crossref
Cintia Muñoz-Quiles, Javier Díez-Domingo, Luis Acedo, Víctor Sánchez-Alonso & Rafael J. Villanueva. (2021) On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model. Viruses 13:5, pages 906.
Crossref
Steven Simoens, Andre Bento-Abreu, Barbara Merckx, Sophie Joubert, Steve Vermeersch, Andrew Pavelyev, Stefan Varga & Edith Morais. (2021) Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium. Frontiers in Pharmacology 12.
Crossref
Javier Díez-Domingo, Víctor Sánchez-Alonso, Rafael-J. Villanueva, Luis Acedo & José Tuells. (2021) Impact of a Gender-Neutral HPV Vaccination Program in Men Who Have Sex with Men (MSM). International Journal of Environmental Research and Public Health 18:3, pages 963.
Crossref
Rashidul Alam Mahumud, Jeff Gow, Khorshed Alam, Syed Afroz Keramat, Md Golam Hossain, Marufa Sultana, Abdur Razzaque Sarker & Sheikh M. Shariful Islam. (2020) Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh. Vaccine 38:2, pages 165-172.
Crossref
Rashidul Alam Mahumud, Khorshed Alam, Jeff Dunn & Jeff Gow. (2019) The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia. PLOS ONE 14:10, pages e0223658.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.